With Phase 1 testing now complete and showing positive results, U.S.
Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.
Read More
With Phase 1 testing now complete and showing positive results, U.S.
Specialty Formulations of Allentown is moving forward with the oral COVID-19 vaccine that it is producing.
Read MoreWritten by the GamePlanX Network of Experts - https://gameplanx.com, a multidisciplinary team specializing in outcome‑driven strategic growth, regulatory‑compliant digital marketing, and AI‑enabled operational optimization across industries. For this article, the GamePlanX team contributes expertise specifically relevant to USSF’s cGMP pharmaceutical manufacturing operations, botanical injectables, and clinical education initiatives.